Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

Maliazurina B. Saad, Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi, Kang Qin, Sheeba J. Sujit, Xuetao Lu, Elliana Young, Qasem Al-Tashi, Rizwan Qureshi, Carol C. Wu, Brett W. Carter, Steven H. Lin, Percy P Lee, Saumil Gandhi, Joe Y. Chang, Ruijiang Li, Michael F. GensheimerHeather A. Wakelee, Joel W. Neal, Hyun Sung Lee, Chao Cheng, Vamsidhar Velcheti, Yanyan Lou, Milena Petranovic, Waree Rinsurongkawong, Xiuning Le, Vadeerat Rinsurongkawong, Amy Spelman, Yasir Y. Elamin, Marcelo V. Negrao, Ferdinandos Skoulidis, Carl M. Gay, Tina Cascone, Mara B. Antonoff, Boris Sepesi, Jeff Lewis, Ignacio I. Wistuba, John D. Hazle, Caroline Chung, David Jaffray, Don L. Gibbons, Ara Vaporciyan, J. Jack Lee, John V. Heymach, Jianjun Zhang, Jia Wu

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences